🔗 Share this article

A shadow economy for unapproved slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors promote the drug there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and chemists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.

Several professionals said the demand for retatrutide could be connected to the increasing price of approved slimming products such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Elimination

According to the social media company, the platform has taken down violative material and banned associated hashtags and search suggestions. The company said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, populated with images of weight loss, glowing reviews and detailed instructions for mixing or administering at residence.

Within minutes of joining one group, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, health issues or past usage.

Product Details and Pricing

Within these communities, messages show black plastic packages with Royal Mail labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram stated it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they can’t verify. Even if the science behind retatrutide is valid, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously seen individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to potentially significant health risks”.